The numbers are real. AGIBOT shipped more humanoid robots in 2025 than any other company on Earth. While Western competitors were showing polished demos and raising billion-dollar rounds, AGIBOT was rolling robots off a production line in Shanghai and putting them into commercial service across eight industries. That's not hype — it's manufacturing at a scale that Tesla Optimus, Figure, and every other Western humanoid program hasn't yet matched.

What AGIBOT gets right:

• Production maturity. 5,168 units shipped isn't a rounding error. The company has a working factory, repeatable manufacturing processes, and a proven supply chain. When buyers ask "can you deliver?", AGIBOT has receipts.
• Portfolio breadth. No other humanoid company offers this range — from $20K education robots to $190K enterprise humanoids to industrial precision platforms. The "One Robotic Body, Three Intelligences" framework isn't marketing fluff; it's an efficient architecture allowing rapid variant development.
• The G2 industrial story. Sub-millimeter precision, automotive-grade durability, force-controlled manipulation, and NVIDIA Jetson Thor compute — the G2 is a serious industrial tool, not a demo bot. Orders in the hundreds of millions of yuan back this up.
• RaaS model. Starting at €899/day with 17-country coverage lowers the adoption barrier significantly. Renting before buying is how enterprise robotics should work.
• NVIDIA integration. GR00T partnership, Jetson Thor compute, Isaac Sim-based training — AGIBOT is deeply embedded in the dominant robotics infrastructure stack.

What gives us pause:

• Chinese data handling for Western buyers. For US and European enterprises handling sensitive operational data, deploying Chinese-manufactured robots with Chinese-developed AI stacks raises real compliance and security questions. AGIBOT's triple certification (China/US/EU) helps, but data residency and sovereignty concerns aren't solved by hardware certifications alone.
• Limited Western support infrastructure. AGIBOT coordinates with "local partners" for support, but this is not the same as having a dedicated US service team like Agility Robotics or Boston Dynamics. For mission-critical industrial deployments, the support gap matters.
• Demo-vs-deployment gap. The Expedition A3's kung fu is spectacular, and AGIBOT Night was unprecedented. But aerial flying kicks don't translate to warehouse efficiency or assembly line throughput. The G2's industrial demos are more commercially relevant, but long-term real-world deployment data in non-Chinese environments remains limited.
• Executive turnover. Multiple senior departures in 2025 — including the Lingxi division president, co-founder Yan Weixin, the algorithm director, and the manufacturing head — suggest internal instability, particularly ahead of a high-profile IPO.
• Pricing opacity. The G2 and A3 are quote-based, making apples-to-apples comparisons difficult for procurement teams. Unitree publishes prices publicly; AGIBOT largely doesn't.
• Geopolitical headwinds. US-China tech tensions could affect AGIBOT's access to NVIDIA chips, its US market expansion plans, and enterprise buyer willingness to commit to a Chinese robotics platform. This is a systemic risk, not specific to AGIBOT, but it's relevant for any Western buyer evaluating a multi-year deployment.

Bottom line: AGIBOT is the single most important humanoid robot company that most Western buyers haven't heard of yet. Their production scale is unmatched, their portfolio is the broadest in the industry, and their NVIDIA partnership validates their technical approach. For Chinese and Asian enterprise buyers, the A2 and G2 are compelling choices today. For North American and European buyers, the calculus is more complex — the robots may be excellent, but the support ecosystem, data handling questions, and geopolitical risks require careful evaluation. BotInfo recommends AGIBOT for enterprise buyers who can manage the due diligence, and suggests Unitree alternatives for buyers who prioritize purchasing simplicity and established Western distribution.